The epidemiology of cutaneous melanoma in the Krasnodar region

S. A Yargunin; M. V Kazantseva; I. S Davidenko; E. V Semenihin

doi:10.17816/onco40043

Russian Journal of Oncology ›› 2013, Vol. 18 ›› Issue (6) : 36 -38. DOI: 10.17816/onco40043

Articles

research-article

The epidemiology of cutaneous melanoma in the Krasnodar region

Author information +

History +

PDF

Abstract

The purpose of the study — an analysis of the incidence of the MC of the Krasnodar region in the past 15 years. Methods. Studied a population-based cancer registry of Krasnodar region on the incidence of MK by sex, age, stage, morphological verification. Results. The incidence of MC in 1998 was 5.1 per 100 thousand population of the province, in 2012 it reached 8.2 per 100 thousand population.conclusions:1. During the period from 1997 to 2012, the incidence of MK rose by 60,8%.2. Against the backdrop of growth in incidence MK One-year mortality increased by 11%.3. The neglect has decreased from 35,4% to 20.5% by 41,3%.

Keywords

skin melanoma / epidemiology

Cite this article

Download citation ▾

S. A Yargunin, M. V Kazantseva, I. S Davidenko, E. V Semenihin. The epidemiology of cutaneous melanoma in the Krasnodar region. Russian Journal of Oncology, 2013, 18(6): 36-38 DOI:10.17816/onco40043

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Алиев М.Д. Диагностика и факторы прогноза меланомы кожи. Саркомы костей, мягких тканей и опухоли кожи. 2010;1: 3—6.

[2]	Egger M.E., Dunki-Jacobs E.M., Callender G.G., Quillo A.R., Scoggins C.R., Martin R.C. 2nd, Stromberg A.J., McMasters K.M. Outcomes and prognostic factors in nodular melanomas. Surgery. 2012; 152(4): 652—9.

[3]	Wisco O.J., Sober A.J. Prognostic factors for melanoma. Dermatol. Clin. 2012; 30(3): 469—85.

[4]	Parrett B.M., Kashani-Sabet M., Singer M.I., Li R., Thummala S., Fadaki N., Leong S.P Long-term prognosis and significance of the sentinel lymph node in head and neck melanoma. Otolaryngol Head Neck Surg. 2012; 147(4): 699—706.

[5]	Казанцева М.В., Тесленко Л.Г., Цокур И.В., Бондарева И.С. Злокачественные новообразования в Краснодарском крае (2008—2012 годы). Состояние онкологической помощи. Краснодар, 2013.

[6]	Чиссов В.И., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2011 году. М.; 2012.

[7]	Read J. Recent advances in cutaneous melanoma: towards a molecular model and targeted treatment. Australas J. Dermatol. 2013 Jan 18. doi: 10.1111/ajd.12013.

[8]	Griewank K.G., Ugurel S., Schadendorf D., Paschen A. New developments in biomarkers for melanoma. Curr Opin Oncol. 2013; 25(2): 145—51.

[9]	Albrecht K., Droll H., Giesler J.M., Nashan D., Meiss F., Reuter K. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression. Psychooncology. 2013 Jan 3. doi: 10.1002/pon.3238.

[10]	Sadeghi M., Lee T., Lui H., McLean D., Atkins S. Detection and analysis of rregular streaks in dermoscopic images of skin lesions. IEEE Trans Med Imag. 2013; 32(5): 849—61.

[11]	Харатишвили Т.К., Белышева Т.С., Вишневская Я.В., Дорошенко М.Б., Колобяков А.А., Алиев М.Д. Возможности ранней диагностики опухолей кожи с использованием современных неинвазивных методов визуализации. Саркомы костей, мягких тканей и опухоли кожи. 2010;1: 61—77.

[12]	Morton R.L., Rychetnik L., McCaffery K., Thompson J.F., Irwig L. Patients’ perspectives of long-term follow-up for localised cutaneous melanoma. Eur J. Surg. Oncol. 2013 Jan 1. doi:pii: S0748-7983(12)01376-5. 10.1016/j.ejso.2012.12.017.